Melioidosis Vaccines: A Systematic Review and Appraisal of the Potential to Exploit Biodefense Vaccines for Public Health Purposes
The designation of Burkholderia pseudomallei as a category B select agent has resulted in considerable research funding to develop a protective vaccine. This bacterium also causes a naturally occurring disease (melioidosis), an important cause of death in many countries including Thailand and Austra...
Main Authors: | Peacock, Sharon J., Limmathurotsakul, Direk, Lubell, Yoel, Koh, Gavin C. K. W., White, Lisa J., Day, Nicholas P. J., Titball, Richard W. |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269417/ |
Similar Items
-
Correction: Melioidosis Vaccines: A Systematic Review and Appraisal of the Potential to Exploit Biodefense Vaccines for Public Health Purposes
by: Peacock, Sharon J., et al.
Published: (2013) -
Consensus on the Development of Vaccines against Naturally Acquired Melioidosis
by: Limmathurotsakul, Direk, et al.
Published: (2015) -
Cost-effectiveness analysis of parenteral antimicrobials for acute melioidosis in Thailand
by: Hantrakun, Viriya, et al.
Published: (2015) -
New Insights from the 7th World Melioidosis Congress 2013
by: Schweizer, Herbert P., et al.
Published: (2014) -
Host Responses to Melioidosis and Tuberculosis Are Both Dominated by Interferon-Mediated Signaling
by: Koh, Gavin C. K. W., et al.
Published: (2013)